Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, gaining muscle while on Mounjaro is possible — but it takes deliberate effort. Tirzepatide reduces appetite significantly, which means protein intake and resistance training need active attention. Without both, the body can lose lean mass alongside fat. Here is what the evidence says and how to build muscle strategically during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist. It reduces hunger and slows how quickly the stomach empties, which is why it produces substantial weight loss in clinical trials, the SURMOUNT-1 trial reported an average reduction of around 20–21% of body weight at the 15 mg dose over 72 weeks. The challenge with any significant calorie deficit is that the body does not distinguish neatly between fat and muscle when it draws on stored energy. That is not unique to tirzepatide; it applies to any effective weight-loss approach.
What tirzepatide does particularly well is reduce overall food intake without requiring constant willpower. The flip side is that if you are eating considerably less, you can drift below the protein threshold your muscles need to repair and grow. Research consistently shows that a higher protein intake during calorie restriction reduces the proportion of weight lost from lean mass. So the question of whether you can gain muscle on Mounjaro is really a question of whether you can hit adequate protein targets while eating less overall. For most people, the answer is yes, with planning. The full overview of how Mounjaro works covers the mechanism in more detail if you want the background first.
The general recommendation from sports nutrition research is around 1.6–2.2 g of protein per kilogram of bodyweight per day for people trying to preserve or build muscle. On tirzepatide, where appetite is suppressed, hitting that range means making protein the first priority at every meal rather than leaving it to chance. Chicken, fish, eggs, Greek yogurt, cottage cheese, tofu, and pulses are all practical high-protein, lower-calorie choices that fit well within the kind of meals most people manage while on treatment.
A practical habit: build your plate protein-first before adding anything else. On a day when nausea makes a full meal difficult (which is most common in the early weeks after starting or after a dose increase) a protein shake, some scrambled eggs, or even a handful of edamame can keep intake from falling too far. Our guide on fasting and Mounjaro covers what happens to the body during extended low-intake periods, which is directly relevant here. A dietitian can work out precise personal targets; your prescriber can flag whether your current dose timing is contributing to particularly difficult appetite windows.
Protein alone is not enough. The body needs a reason to hold onto muscle, and resistance exercise provides that signal. Even two sessions per week of compound movements (squats, deadlifts, rows, press-ups) are enough to send a meaningful stimulus to muscle fibres. You do not need to train like a competitive bodybuilder. Consistency matters more than volume, especially when energy may be lower during the early phase of treatment.
Progressive overload (gradually increasing the weight or reps over weeks) is what drives actual muscle gain over time. People who combine adequate protein with resistance training during calorie restriction consistently retain more lean mass than those who rely on diet alone. The broader picture of muscle outcomes on tirzepatide is explored in our dedicated tirzepatide and muscle gain page, including what the trial data shows about lean mass versus fat mass changes. One thing our prescribers hear fairly often: people feel stronger after a few months on treatment than they expected, partly because carrying less weight makes movement easier and partly because purposeful protein and training compound over time. Worth knowing before you start.
Body composition is not static. As your dose increases through the titration schedule (treatment starts at 2.5 mg and is typically increased in four-week steps) your appetite may fall further, and you may need to revisit your protein and calorie approach. Regular check-ins with a prescriber are the right place to flag if you feel you are losing strength or energy rather than just weight. The detail on muscle loss and Mounjaro covers the warning signs that lean mass is being affected disproportionately.
One practical note: if you are tracking progress, scales alone are a poor measure of body composition. Body measurements, how clothes fit, and how much weight you can lift in the gym give a more complete picture than weight alone. For a closer look at the evidence on what tirzepatide does to muscle tissue specifically, the muscle loss page pulls together what the published data currently shows. And if you are considering treatment and want to understand the full case for building muscle on Mounjaro, that page covers the optimistic side of the evidence too. The NHS tirzepatide information page also outlines recommended lifestyle changes alongside treatment, including physical activity guidance. For the clinical trial detail behind the weight-loss figures, the SURMOUNT-1 paper in the New England Journal of Medicine is the primary reference.
If you are thinking about starting Mounjaro and want to discuss how to structure your approach to training and nutrition alongside treatment, speaking to our prescribers is a good first step. The consultation is free, and a clinician (not an algorithm) reviews your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.